TLC and 3SBio Form Exclusive Partnership to Commercialize Two NanoX™ Products in Mainland China

    NEXT STORY
    Novartis data confirm rapid response and high efficacy of Cosentyx® in psoriasis patients for first time in China
    PREV STORY
    Verrica Pharmaceuticals Presents Positive Results from Two Phase 3 Clinical Trials of VP-102 in Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chiasma Expands Senior Management Team With Key Strategic Hires

    NEWTON, Mass., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Crisp Regional Health, Inc. Selects Cerner Integrated EHR to Support Improved Patient Care

    CORDELE, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Crisp Regional Health, Inc. has selected ...

    author_avatar
    NASDAQ Market News

    iCAD Reports First Quarter 2016 Financial Results

    Reports Progress with Reimbursement Under New CPT 3 Code for the Treatment of Non-melanoma ...

    author_avatar
    NASDAQ Market News